Company news
Rani Therapeutics Holdings, Inc. news in 2024
Rani Therapeutics Holdings, Inc.'s news releases, calls and decks from 2024, newest first.
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
November 13, 2024
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
October 16, 2024
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
October 14, 2024
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update
August 5, 2024
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
July 21, 2024
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
June 23, 2024
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
May 5, 2024
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
March 19, 2024
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
February 4, 2024
Calls in 2024
Decks in 2024
- Corporate Update (June 2024)
Corporate update · 34 slides · Jun 24, 2024
- Investor Presentation (February 2024)
Investor deck · 37 slides · Feb 5, 2024